3522集团新网站(中国)有限公司
中文
英文
Home
About Us
Overview
Our People
Our Workplace
Products
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Solutions
Chemistry
Custom Chemical Synthesis
FTE
Biology Services
In Vivo Efficacy Evaluation1
In Vitro Biological Screening
DMPK
In Vivo Pharmacokinetic Assays
In Vitro Pharmacokinetic Assays
Drug Safety Evaluation
News
Recruitment
Recruitment
Contact Us
中文版
Product center
Hypoglycemic drugs
Antineoplastic
Cardiovascular drugs
Others
Contact Us
Tel:
86-21-64556180
Fax:
86-21-69018966*808
Add:Floor 4,Building 6, Quwu Road, 589, Minhang District, Shanghai, China.
Zip code:
200241
Contact:Linna
Q Q:2300432737
E-mail:
cpd-service@caerulumpharma.com
Web
:www.caerulumpharma.com
Products
No.
Product Name
CAS Number
Structure
CPDB041
Ceritinib; LDK378
1032900-25-6;
1380575-43-8(2HCl)
CPDB0483
VX-11e
896720-20-0
CPDB053
AZD4547
1035270-39-3
CPDB0547
BDA-366
NA
CPDB070
Ibrutinib;PCI-32765
936563-96-1
CPDB0700
6-bromo-8-cyclopentyl-5-methyl-2-(methylsulfinyl)pyrido[2,3-d]pyrimidin-7(8H)-one
571188-81-3
CPDB0716
(E)-3,5-dichloro-4-(3-methoxy-2-methyl-3-oxoprop-1-en-1-yl)benzoic acid
1110767-89-9
CPDB075
Palbociclib HCl; PD0332991 HCl
827022-32-2
CPDB081
GSK 2606414
1337531-36-8
CPDB089
Dabrafenib; GSK 2118436
1195765-45-7
CPDB0898
SAR-020106
1184843-57-9
CPDB0907
CB-5083
1542705-92-9
CPDB0926
AP-26113 , Brigatinib
1197953-54-0
CPDB0934
EAI045
1942114-09-1
CPDB0942
BLU-554
1707289-21-1
31
32
33
34
35
36
37
38
39
40
Copyright 2014 Shanghai Caerulum Pharma Discovery Co.,Ltd. All rights reserved. Supported by
www.hxchem.net